232 related articles for article (PubMed ID: 10027831)
1. Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions.
Reilly TP; Woster PM; Svensson CK
J Pharmacol Exp Ther; 1999 Mar; 288(3):951-9. PubMed ID: 10027831
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes.
Vyas PM; Roychowdhury S; Woster PM; Svensson CK
Biochem Pharmacol; 2005 Jul; 70(2):275-86. PubMed ID: 15894292
[TBL] [Abstract][Full Text] [Related]
3. Dapsone-induced hematologic toxicity: comparison of the methemoglobin-forming ability of hydroxylamine metabolites of dapsone in rat and human blood.
Vage C; Saab N; Woster PM; Svensson CK
Toxicol Appl Pharmacol; 1994 Dec; 129(2):309-16. PubMed ID: 7992320
[TBL] [Abstract][Full Text] [Related]
4. Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?
Reilly TP; MacArthur RD; Farrough MJ; Crane LR; Woster PM; Svensson CK
J Pharmacol Exp Ther; 1999 Dec; 291(3):1356-64. PubMed ID: 10565861
[TBL] [Abstract][Full Text] [Related]
5. Effect of pro-inflammatory cytokines on the toxicity of the arylhydroxylamine metabolites of sulphamethoxazole and dapsone in normal human keratinocytes.
Khan FD; Roychowdhury S; Nemes R; Vyas PM; Woster PM; Svensson CK
Toxicology; 2006 Feb; 218(2-3):90-9. PubMed ID: 16289751
[TBL] [Abstract][Full Text] [Related]
6. Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia.
Grossman SJ; Jollow DJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):118-25. PubMed ID: 3335994
[TBL] [Abstract][Full Text] [Related]
7. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.
Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A
Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605
[TBL] [Abstract][Full Text] [Related]
8. Two mechanisms for toxic effects of hydroxylamines in human erythrocytes: involvement of free radicals and risk of potentiation.
Evelo CT; Spooren AA; Bisschops RA; Baars LG; Neis JM
Blood Cells Mol Dis; 1998 Sep; 24(3):280-95. PubMed ID: 10087986
[TBL] [Abstract][Full Text] [Related]
9. Formation and uptake of arylhydroxylamine-haptenated proteins in human dendritic cells.
Roychowdhury S; Vyas PM; Svensson CK
Drug Metab Dispos; 2007 Apr; 35(4):676-81. PubMed ID: 17220235
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.
Roychowdhury S; Vyas PM; Reilly TP; Gaspari AA; Svensson CK
J Pharmacol Exp Ther; 2005 Jul; 314(1):43-52. PubMed ID: 15784651
[TBL] [Abstract][Full Text] [Related]
11. Dapsone-induced hemolytic anemia.
Jollow DJ; Bradshaw TP; McMillan DC
Drug Metab Rev; 1995; 27(1-2):107-24. PubMed ID: 7641572
[TBL] [Abstract][Full Text] [Related]
12. Hemolysis and Metabolic Lesion of G6PD Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model.
Dziewulska KH; Reisz JA; Hay AM; D'Alessandro A; Zimring JC
J Pharmacol Exp Ther; 2023 Sep; 386(3):323-330. PubMed ID: 37348965
[TBL] [Abstract][Full Text] [Related]
13. Role of lipid peroxidation in dapsone-induced hemolytic anemia.
McMillan DC; Jensen CB; Jollow DJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):868-76. PubMed ID: 9864266
[TBL] [Abstract][Full Text] [Related]
14. A study on the interaction between hydroxylamine analogues and oxyhemoglobin in intact erythrocytes.
Spooren AA; Evelo CT
Blood Cells Mol Dis; 2000 Aug; 26(4):373-86. PubMed ID: 11042038
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat.
Gill HJ; Hough SJ; Naisbitt DJ; Maggs JL; Kitteringham NR; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 1997 Aug; 282(2):795-801. PubMed ID: 9262343
[TBL] [Abstract][Full Text] [Related]
16. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.
Irshaid Y; Adedoyin A; Lotze M; Branch RA
Drug Metab Dispos; 1994; 22(1):161-4. PubMed ID: 8149877
[TBL] [Abstract][Full Text] [Related]
17. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity.
Cribb AE; Miller M; Leeder JS; Hill J; Spielberg SP
Drug Metab Dispos; 1991; 19(5):900-6. PubMed ID: 1686233
[TBL] [Abstract][Full Text] [Related]
18. Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts.
Bhaiya P; Roychowdhury S; Vyas PM; Doll MA; Hein DW; Svensson CK
Toxicol Appl Pharmacol; 2006 Sep; 215(2):158-67. PubMed ID: 16603214
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of K-C1 cotransport in rat red cells by a hemolytic anemia-producing metabolite of dapsone.
Haas M; Harrison JH
Am J Physiol; 1989 Feb; 256(2 Pt 1):C265-72. PubMed ID: 2919657
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone.
Reilly TP; Bellevue FH; Woster PM; Svensson CK
Biochem Pharmacol; 1998 Mar; 55(6):803-10. PubMed ID: 9586952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
